These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 27383016)

  • 41. Sprouting strategies and dead ends in anti-angiogenic targeting of NETs.
    Carrasco P; Zuazo-Gaztelu I; Casanovas O
    J Mol Endocrinol; 2017 Jul; 59(1):R77-R91. PubMed ID: 28469004
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular Pathways Mediating Metastases to the Brain via Epithelial-to-Mesenchymal Transition: Genes, Proteins, and Functional Analysis.
    Jeevan DS; Cooper JB; Braun A; Murali R; Jhanwar-Uniyal M
    Anticancer Res; 2016 Feb; 36(2):523-32. PubMed ID: 26851006
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Roles of MicroRNA-141 in Human Cancers: From Diagnosis to Treatment.
    Gao Y; Feng B; Han S; Zhang K; Chen J; Li C; Wang R; Chen L
    Cell Physiol Biochem; 2016; 38(2):427-48. PubMed ID: 26828359
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of CSL-dependent and independent Notch signaling pathways in cell apoptosis.
    Zeng C; Xing R; Liu J; Xing F
    Apoptosis; 2016 Jan; 21(1):1-12. PubMed ID: 26496776
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fibroblast growth factors and their receptors in cancer.
    Wesche J; Haglund K; Haugsten EM
    Biochem J; 2011 Jul; 437(2):199-213. PubMed ID: 21711248
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Growth factors controlling angiogenesis and lymphangiogenesis.
    Alitalo K
    Ugeskr Laeger; 2002 Jun; 164(24):3170-2. PubMed ID: 12082760
    [No Abstract]   [Full Text] [Related]  

  • 47. Notch Signaling Function in the Angiocrine Regulation of Tumor Development.
    Trindade A; Duarte A
    Cells; 2020 Nov; 9(11):. PubMed ID: 33198378
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pericytes: gatekeepers in tumour cell metastasis?
    Gerhardt H; Semb H
    J Mol Med (Berl); 2008 Feb; 86(2):135-44. PubMed ID: 17891366
    [TBL] [Abstract][Full Text] [Related]  

  • 49. From junk to master regulators of invasion: lncRNA functions in migration, EMT and metastasis.
    Dhamija S; Diederichs S
    Int J Cancer; 2016 Jul; 139(2):269-80. PubMed ID: 26875870
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.
    Zhao Y; Adjei AA
    Oncologist; 2015 Jun; 20(6):660-73. PubMed ID: 26001391
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Role of Interleukin-17 in Lung Cancer.
    Wu F; Xu J; Huang Q; Han J; Duan L; Fan J; Lv Z; Guo M; Hu G; Chen L; Zhang S; Tao X; Ma W; Jin Y
    Mediators Inflamm; 2016; 2016():8494079. PubMed ID: 27872514
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epithelial-mesenchymal transition in morphogenesis, cancer progression and angiogenesis.
    Ribatti D
    Exp Cell Res; 2017 Apr; 353(1):1-5. PubMed ID: 28257786
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A practical toolkit to study aspects of the metastatic cascade in vitro.
    Pantazi P; Carollo E; Carter DRF; Brooks SA
    Acta Histochem; 2020 Dec; 122(8):151654. PubMed ID: 33157489
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tumor cell-mediated neovascularization and lymphangiogenesis contrive tumor progression and cancer metastasis.
    Cao Z; Shang B; Zhang G; Miele L; Sarkar FH; Wang Z; Zhou Q
    Biochim Biophys Acta; 2013 Dec; 1836(2):273-86. PubMed ID: 23933263
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CUL4A facilitates hepatocarcinogenesis by promoting cell cycle progression and epithelial-mesenchymal transition.
    Pan Y; Wang B; Yang X; Bai F; Xu Q; Li X; Gao L; Ma C; Liang X
    Sci Rep; 2015 Nov; 5():17006. PubMed ID: 26593394
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PI3K signalling is required for a TGFβ-induced epithelial-mesenchymal-like transition (EMT-like) in human melanoma cells.
    Schlegel NC; von Planta A; Widmer DS; Dummer R; Christofori G
    Exp Dermatol; 2015 Jan; 24(1):22-8. PubMed ID: 25363503
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Soluble factors regulated by epithelial-mesenchymal transition mediate tumour angiogenesis and myeloid cell recruitment.
    Suarez-Carmona M; Bourcy M; Lesage J; Leroi N; Syne L; Blacher S; Hubert P; Erpicum C; Foidart JM; Delvenne P; Birembaut P; Noël A; Polette M; Gilles C
    J Pathol; 2015 Aug; 236(4):491-504. PubMed ID: 25880038
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Suppression of migratory and metastatic pathways via blocking VEGFR1 and VEGFR2.
    Sadremomtaz A; Kobarfard F; Mansouri K; Mirzanejad L; Asghari SM
    J Recept Signal Transduct Res; 2018; 38(5-6):432-441. PubMed ID: 30929546
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Associations of FGF-3 and FGF-10 with signaling networks regulating tooth morphogenesis.
    Kettunen P; Laurikkala J; Itäranta P; Vainio S; Itoh N; Thesleff I
    Dev Dyn; 2000 Nov; 219(3):322-32. PubMed ID: 11066089
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CXCL4L1-fibstatin cooperation inhibits tumor angiogenesis, lymphangiogenesis and metastasis.
    Prats AC; Van den Berghe L; Rayssac A; Ainaoui N; Morfoisse F; Pujol F; Legonidec S; Bikfalvi A; Prats H; Pyronnet S; Garmy-Susini B
    Microvasc Res; 2013 Sep; 89():25-33. PubMed ID: 23747987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.